Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 200815-49-2, Brovana, (r,r)-arformoterol tartrate, Arformoterol tartrate [usan], 5p8vj2i235, Arformoterol tartrate (usan)
Molecular Formula
C23H30N2O10
Molecular Weight
494.5  g/mol
InChI Key
FCSXYHUNDAXDRH-OKMNHOJOSA-N
FDA UNII
5P8VJ2I235

Arformoterol Tartrate is the tartrate salt of arformoterol, the (R,R)-enantiomer of formoterol and a long-acting beta-2 adrenergic agonist with bronchodilator activity. Arformoterol selectively binds to and activates beta-2 adrenergic receptors in bronchiolar smooth muscle, thereby causing stimulation of adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased intracellular cAMP levels cause relaxation of bronchial smooth muscle and lead to an inhibition of release of inflammatory mediators from mast cells. This may eventually lead to an improvement of airway function.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3R)-2,3-dihydroxybutanedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
2.1.2 InChI
InChI=1S/C19H24N2O4.C4H6O6/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-1(3(7)8)2(6)4(9)10/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t13-,19+;1-,2-/m11/s1
2.1.3 InChI Key
FCSXYHUNDAXDRH-OKMNHOJOSA-N
2.1.4 Canonical SMILES
CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(C(C(=O)O)O)(C(=O)O)O
2.1.5 Isomeric SMILES
C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
5P8VJ2I235
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 200815-49-2

2. Brovana

3. (r,r)-arformoterol Tartrate

4. Arformoterol Tartrate [usan]

5. 5p8vj2i235

6. Arformoterol Tartrate (usan)

7. Formamide, N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)

8. (r,r)-formoterol Tartrate

9. (-)-n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide Hydrogen (2r,3r)-2,3-dihydroxybutanedioate (salt)

10. Formamide, N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)

11. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)

12. Brovana Inhalation Solution

13. Unii-5p8vj2i235

14. Brovana (tn)

15. Arformotero Ltartrate

16. Dtxsid80173903

17. Arformoterol Tartrate [vandf]

18. S5217

19. Arformoterol Tartrate [mart.]

20. Akos005145740

21. Arformoterol Tartrate [who-dd]

22. Ccg-269651

23. Arformoterol Tartrate, >=98% (hplc)

24. Ba171831

25. Bs-42158

26. Arformoterol Tartrate [orange Book]

27. Formoterol R,r-form L-tartrate [mi]

28. D02981

29. 815f492

30. Q-101035

31. Q27262686

32. (2r,3r)-2,3-dihydroxybutanedioic Acid;n-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide

33. (r,r)-formoterol Tartrate; N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1)

34. [(2r)-2-(3-formamido-4-hydroxyphenyl)-2-hydroxyethyl]-[(2r)-1-(4-methoxyphenyl)propan-2-yl]azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate

35. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutane Dioate

36. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutanedioate

37. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 494.5 g/mol
Molecular Formula C23H30N2O10
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count11
Rotatable Bond Count11
Exact Mass494.19004516 g/mol
Monoisotopic Mass494.19004516 g/mol
Topological Polar Surface Area206 Ų
Heavy Atom Count35
Formal Charge0
Complexity521
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameBrovana
PubMed HealthArformoterol (By breathing)
Drug ClassesBronchodilator
Active IngredientArformoterol tartrate
Dosage FormSolution
RouteInhalation
Strengtheq 0.015mg base/2ml
Market StatusPrescription
CompanySunovion

2 of 2  
Drug NameBrovana
PubMed HealthArformoterol (By breathing)
Drug ClassesBronchodilator
Active IngredientArformoterol tartrate
Dosage FormSolution
RouteInhalation
Strengtheq 0.015mg base/2ml
Market StatusPrescription
CompanySunovion

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
beta2-Adrenergic Agonist [EPC]; Adrenergic beta2-Agonists [MoA]